Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).


TSXV:MPH - Post by User

Comment by Checkouton Nov 13, 2023 11:04am
114 Views
Post# 35731941

RE:RE:RE:a couple of jokers with no cents, non sense etc

RE:RE:RE:a couple of jokers with no cents, non sense etcwhy dont you call the company and ask them if your so interested in a correct answer to your insinuating question. 

Here are 6 reasons to invest in Medicure:
  1. Profitable and growing profit
  2. Steady sales of Aggrastat (tirofiban hydrochloride) injection
  3. Growing sales of Zypitamag (pitavastatin) tablets
  4. No debt
  5. Eligible for a priority review voucher upon completion of a Phase 3 trial of 10 rare pediatric disease patients (valued at $100M)
  6. Marley Drug - a growing E-commerce pharmacy subsidiary
https://mailchi.mp/1022e1acf952/6-reasons-to-invest-in-medicure?e=d7939b6781
<< Previous
Bullboard Posts
Next >>